Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker
about
Reverse phase protein microarrays advance to use in clinical trialsSerum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.Highly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patients.Elucidation of the CHO Super-Ome (CHO-SO) by Proteoinformatics.Systematic antibody and antigen-based proteomic profiling with microarrays.Array-based proteomic approaches to study signal transduction pathways: prospects, merits and challenges.High-Density Serum/Plasma Reverse Phase Protein Arrays.An 8 minute colorimetric paper-based reverse phase vertical flow serum microarray for screening of hyper IgE syndrome.
P2860
Q28384553-1CDDFC25-83E7-45DF-9248-C42CEB43F3A7Q33514817-5C4D193B-B221-4B41-9139-1CA8CDD1EB4FQ33891197-1A04121A-2AD6-4935-B6BA-2CCC468F6D22Q35735913-A5FE1A1E-B80C-4FCD-A8CF-1131DC84C323Q36487059-D3EA1D94-BBEE-46EF-A3CB-DD862EC129B4Q37853185-CBF6B15F-BC5F-4618-9ACA-320A2E1CF7A3Q38255299-F5A0FCA7-C01E-4409-B691-F9CFC9858CFDQ48733544-A289F1A3-A95C-47A5-994B-D1C9EACAEF08Q53671747-10FA7803-9C7C-49F2-9D61-BBFA763443B5
P2860
Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Development of reverse phase p ...... a mid-abundant blood biomarker
@ast
Development of reverse phase p ...... a mid-abundant blood biomarker
@en
type
label
Development of reverse phase p ...... a mid-abundant blood biomarker
@ast
Development of reverse phase p ...... a mid-abundant blood biomarker
@en
prefLabel
Development of reverse phase p ...... a mid-abundant blood biomarker
@ast
Development of reverse phase p ...... a mid-abundant blood biomarker
@en
P2093
P2860
P356
P1433
P1476
Development of reverse phase p ...... a mid-abundant blood biomarker
@en
P2093
Adriana Aguilar-Mahecha
Andre Nantel
Christiane Cantin
Mark Basik
Maureen O'Connor-McCourt
P2860
P2888
P356
10.1186/1477-5956-7-15
P577
2009-04-06T00:00:00Z
P5875
P6179
1018341046